Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat <i>Acinetobacter baumannii</i>: From Screening Impurity to <i>In Vivo</i> Efficacy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jason W,Skudlarek

第一单位： Merck & Co., Inc., Rahway, New Jersey 07065, United States.

作者： Jason W,Skudlarek ^[1] ; Andrew J,Cooke ^[1] ; Helen J,Mitchell ^[1] ; Kerim,Babaoglu ^[1] ; Anthony W,Shaw ^[1] ; Ling,Tong ^[1] ; Ashley B,Nomland ^[1] ; Marc,Labroli ^[1] ; Deyou,Sha ^[1] ; James J,Mulhearn ^[1] ; Chengwei,Wu ^[1] ; Sarah W,Li ^[1] ; Douglas C,Beshore ^[1] ; Jonathan M E,Hughes ^[1] ; Matthieu,Jouffroy ^[1] ; Hao,Wang ^[1] ; Carl J,Balibar ^[1] ; Ronald E,Painter ^[1] ; Pamela,Shen ^[1] ; Henry S,Lange ^[1] ; Andrii,Ishchenko ^[1] ; Yun-Ting,Chen ^[1] ; Daniel J,Klein ^[1] ; Rodger W,Tracy ^[1] ; Randy R,Miller ^[1] ; Tamara D,Cabalu ^[1] ; Zhe,Wu ^[1] ; Andrew,Leithead ^[1] ; Giovanna,Scapin ^[1] ; Alan W,Hruza ^[1] ; Liudmila,Dzhekieva ^[1] ; Marina,Bukhtiyarova ^[1] ; Michelle F,Homsher ^[1] ; Min,Xu ^[1] ; Carolyn,Bahnck-Teets ^[1] ; David,McKenney ^[1] ; Alexei V,Buevich ^[1] ; Jian,Liu ^[1] ; Li-Kang,Zhang ^[1] ; Tao,Meng ^[1] ; Terri,Kelly ^[1] ; Edward,DiNunzio ^[1] ; Stephen,Soisson ^[1] ; Robert K Y,Cheng ^[2] ; Michael,Hennig ^[2] ; Izzat,Raheem ^[1] ; Scott S,Walker ^[1]

作者单位： Merck & Co., Inc., Rahway, New Jersey 07065, United States. ^[1] leadXpro AG, CH-5234 Villigen, Switzerland. ^[2]